Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Spurious drugs worth Rs. 6.60 cr seized in Kolkata
The drugs, labelled as being manufactured in various countries including Ireland, Turkey, the USA, and Bangladesh, were found…
Anthem Biosciences files DRHP for Rs 3,395 cr IPO
The company which was incorporated in 2006, has two operational manufacturing facilities in India, Unit I (Bommassandra) and Unit…
Venus Remedies gains GMP certification for Antibiotic-Carbapenemm facility from Moldova’s health…
The Europe carbapenem market generated revenue of $ 1,061.4 million in 2022 and is expected to grow at a CAGR of 4 per cent from…
2025: A year of stricter rules, course corrections?
Will 2025 see a more vigilant government when it comes to violations by pharma companies, be it GMP slip ups or the Uniform Code…
Express Pharma January 2025
India's Foremost Pharma & Biotech Magazine ~ Outlook 2025
Eli Lilly’s Zepbound holds possibility to dominate obesity market
Recently, Eli Lilly announced the results from its SURMOUNT-5 trial, comparing Zepbound and Wegovy’s efficacy on equal grounds
Panel Discussion: Chennai’s competitive edge and emerging leadership
Chennai Pharma Summit 2024 | 20th December 2024
Mr Dhairy Sharma, Sr Executive – Business Development, Cilicant
Chennai Pharma Summit 2024 | 20th December 2024
Mr Kabirdas B, Sr Manager – Business Development, Ami Polymer
Chennai Pharma Summit 2024 | 20th December 2024
Dr Abhijit Gothoskar, Technical Expert, Sigachi Industries
Chennai Pharma Summit 2024 | 20th December 2024